Identification of Druggable Targets for Alzheimer's Disease by Analyzing Circulating Inflammatory Proteins With Mendelian Randomization
Brain and Behavior · 2025-08 · 15 (8)
DOI: 10.1002/brb3.70797 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain and Behavior, online erschienen am 27.08.2025. Verfasst von Hongliang An und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Nanjing Meishan Hospital, Nanjing, China. Hauptthemen laut MEDLINE: Alzheimer Disease. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Young Talent Training Project for Traditional Chinese Medicine of Nanjing.
Themen: Demenz
Abstract (Originalsprache)
Objective
To identify potential druggable targets for Alzheimer's disease (AD) by analyzing circulating inflammatory proteins using Mendelian randomization (MR).
Methods
Two‐sample MR analysis was employed to investigate the causal relationships between 91 circulating inflammatory proteins and AD. The primary MR method utilized was the inverse variance weighted (IVW) model, while the weighted median (WM) and MR‐Egger models were applied for sensitivity analysis. To assess the heterogeneity of instrumental variables (IVs), Cochran's Q ‐test and I 2 statistics were utilized. Additionally, ChEMBL and DGIdb databases with Bayesian colocalization analysis were consulted to identify potential druggable proteins.
Results
MR analysis identified eight inflammatory proteins significantly associated with AD risk. Among these proteins, TNFB [odds ratio (OR): 1.06, 95% Confidence Interval (CI): 1.02–1.11, p = 8.77×10 − 3 ], TSLP (OR: 1.10, 95% CI: 1.01–1.19, p = 0.028), S100A12 (OR: 1.09, 95% CI: 1.01–1.18, p = 0.03), CD244 (OR: 1.07, 95% CI: 1.00–1.13, p = 0.036), and IL33 (OR: 1.08, 95% CI: 1.00 –1.17, p = 0.048) were identified as proteins associated with elevated AD risk. Conversely, three inflammatory proteins exhibited a protective effect against AD, including NRTN (OR: 0.91, 95% CI: 0.85–0.99; p = 0.019), CCL4 (OR: 0.95, 95% CI: 0.91–1.00, p = 0.029), and MMP1 (OR: 0.93, 95% CI: 0.87–1.00, p = 0.049). Notably, according to the gene‐drug analysis, TSLP, S100A12, CD244, CCL4, and MMP1 were identified as druggable. Additionally, MMP1 (PP4 = 0.92) and CCL4 (PP4 = 0.87) in the prefrontal cortex had the strongest colocalization evidence (PP4 > 0.85), suggesting they could potentially serve as novel therapeutic targets for AD.
Conclusions
Integrative genetic analyses indicate that genetically determined circulating levels of TSLP, S100A12, CD244, CCL4, and MMP1 exert causal effects on AD risk. These findings nominate all five proteins as potential therapeutic targets, with MMP1 and CCL4 representing priority candidates warranting further mechanistic investigation and clinical validation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Nanjing Meishan Hospital, Nanjing, China.
- Child Mental Health Research Center, Nanjing Brain Hospital Affiliated to Nanjing Medical University, Nanjing, China.
- Neuro-Psychiatric Institute, Nanjing Brain Hospital Affiliated to Nanjing Medical University, Nanjing, China.
ORCID-Profile: Taiping Li
Förderung
- The Young Talent Training Project for Traditional Chinese Medicine of Nanjing
Zitieren
APA
An, H., Gu, J., & Li, T. (2025). Identification of Druggable Targets for Alzheimer's Disease by Analyzing Circulating Inflammatory Proteins With Mendelian Randomization. Brain and Behavior, 15(8). https://doi.org/10.1002/brb3.70797
Vancouver
An H, Gu J, Li T. Identification of Druggable Targets for Alzheimer's Disease by Analyzing Circulating Inflammatory Proteins With Mendelian Randomization. Brain and Behavior. 2025;15(8). doi:10.1002/brb3.70797
BibTeX
@article{An2025,
author = {An, Hongliang and Gu, Jianhong and Li, Taiping},
title = {Identification of Druggable Targets for Alzheimer's Disease by Analyzing Circulating Inflammatory Proteins With Mendelian Randomization},
journal = {Brain and Behavior},
year = {2025},
volume = {15},
number = {8},
doi = {10.1002/brb3.70797}
}
EUVIMED